SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-14-005412
Filing Date
2014-11-10
Accepted
2014-11-10 16:32:08
Documents
5
Period of Report
2014-11-07
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K dvax-8k_20141110.htm 8-K 38742
2 EX-3.1 dvax-ex31_2014111067.htm EX-3 10673
3 EX-10.1 dvax-ex101_201411106.htm EX-10 245842
4 EX-99.1 dvax-ex991_201411109.htm EX-99 13602
5 GRAPHIC g201411102041106061874.jpg GRAPHIC 28454
  Complete submission text file 0001564590-14-005412.txt   349553
Mailing Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710
Business Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710 5108485100
DYNAVAX TECHNOLOGIES CORP (Filer) CIK: 0001029142 (see all company filings)

IRS No.: 330728374 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34207 | Film No.: 141209108
SIC: 2834 Pharmaceutical Preparations